Early research (Phase 1)Ended earlyNCT06336148What this trial is testingA Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Actym Therapeutics, Inc. 10
Testing effectiveness (Phase 2)WithdrawnNCT03540199What this trial is testingStudy of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney CancerWho this might be right forAdvanced Kidney Cancer Fuda Cancer Hospital, Guangzhou
Testing effectiveness (Phase 2)Study completedNCT02875548What this trial is testingAssess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical StudyWho this might be right forDiffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Synovial Sarcoma+5 more Epizyme, Inc. 58
Early research (Phase 1)Looking for participantsNCT06819293What this trial is testingIB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell CarcinomaWho this might be right forAdvanced Clear Renal Cell CarcinomaAdult Grit Biotechnology 12
Testing effectiveness (Phase 2)Study completedNCT00024258What this trial is testingArsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00035243What this trial is testingEPO906 Therapy in Patients With Advanced Kidney CancerWho this might be right forKidney Neoplasms Novartis Pharmaceuticals 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732What this trial is testingPembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticWho this might be right forAdvanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more M.D. Anderson Cancer Center 157
Early research (Phase 1)Study completedNCT00045006What this trial is testingSuberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT03744585What this trial is testingCabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.Who this might be right forRenal Cell Carcinoma Ipsen 450
Testing effectiveness (Phase 2)Looking for participantsNCT07227415What this trial is testingSymbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell CancerWho this might be right forCarcinoma, Renal CellAdvanced Renal Cell CarcinomaRenal Cancer+10 more Pfizer 224
Early research (Phase 1)Looking for participantsNCT07564232What this trial is testingPhase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT03652298What this trial is testingEffects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and PartnersWho this might be right forColorectal CancerBladder CancerProstate Cancer+2 more Centre Oscar Lambret 19
Testing effectiveness (Phase 2)Study completedNCT00661609What this trial is testingA Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder CancerWho this might be right forBladder CancerTransitional Cell Bladder CancerUrethra Cancer+2 more AstraZeneca 54
Testing effectiveness (Phase 2)Study completedNCT01191892What this trial is testingCarboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUreter Cancer+1 more Cardiff University 82
Early research (Phase 1)Study completedNCT02903914What this trial is testingArginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid TumorsWho this might be right forMetastatic CancerSolid TumorsColorectal Cancer (CRC)+7 more Incyte Corporation 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213704What this trial is testingLarotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more National Cancer Institute (NCI) 9
Early research (Phase 1)Ended earlyNCT04301011What this trial is testingStudy of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid TumorsWho this might be right forSolid TumorMicrosatellite Stable Colorectal CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+6 more Turnstone Biologics, Corp. 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT05879822What this trial is testingEvaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor NaiveWho this might be right forAdvanced Solid Tumor Incyte Corporation 73
Testing effectiveness (Phase 2)Study completedNCT00011973What this trial is testingChemotherapy in Treating Patients With Advanced Kidney CancerWho this might be right forKidney Cancer Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00445523What this trial is testingSafety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal CancerWho this might be right forCarcinoma, Renal Cell The Methodist Hospital Research Institute 28